Fertiliteit
12 april 2021
Archief
First studie
A randomized, double-blind, phase 3 comparison of platinum-based therapy with TSR 042 (dostarlimab) and niraparib versus standard of care platinum-based therapy as first line treatment of stage III…
Foresight
Investigating the occurrence of everolimus long-term side effects by follow up of everolimus through blood concentrations Protocolnummer: Eudract nummer: METc nummer: 2018/631 Onderzoekscode: Samenvatting Het…
Foresight
Foresight
Foresight
G1T48
Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Ascending Doses of G1T48 in Women with Estrogen Receptor-Positive, HER2-Negative Advanced Breast…
G1T48
G1T48
6 mei 2021
Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Ascending Doses of G1T48 in Women with Estrogen Receptor-Positive, HER2-Negative Advanced Breast…
GALLOP-11
12 april 2021
Validation of mutation analysis in circulating tumour DNA with a ddPCR assay as diagnostic and follow-up tool for patients with a KIT exon 11 mutated GIST: GALLOP-11. Protocolnummer:…
GALLOP-11
GALLOP-11
GALLOP-11
GDC-0810
An open-label, phase I/IIA study of GDC-0810 in postmenopausal women with locally advanced or metastatic estrogen receptor positive breast cancer (GO29642) SERD Genentech Protocolnummer: GO29642 Eudract nummer: 2014-004852-77…
GELATO
Een onderzoek naar de veiligheid en werkzaamheid van de behandeling met carboplatin en atezolizumab bij patiënten met uitgezaaide lobulaire borstkanker – de GELATO studie. Protocolnummer: Eudractnummer: 2017-001428-23 METc…
GLOW
A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of Zolbetuximab (IMAB362) Plus CAPOX Compared with Placebo Plus CAPOX as First-line Treatment of Subjects with Claudin (CLDN)18.2-Positive, HER2-Negative,…
GLOW
HER2CLIMB-02
6 september 2021
Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer Protocolnummer: SGNTUC-016 Eudractnummer:…
Holistic
12 april 2021
The HOLISTIC study: Health-related quality Of Life In patients with advanced Soft Tissue sarcomas treated with Chemotherapy Samenvatting Multicenter, longitudinaal cohort studie naar de kwaliteit van leven tijdens…